Imaging Plaque Inflammation in Higher-Risk Patients: What Do We Know and What Are We Looking For?

被引：0
作者：
Ishai A. [1 ]
Tawakol A. [1 ,2 ]
机构：
[1] Cardiac MR PET CT Program, Department of Imaging, Massachusetts General Hospital and Harvard Medical School Boston, 165 Cambridge Street, Suite 400, Boston, 02114-2750, MA
[2] Cardiology Division, Massachusetts General Hospital and Harvard Medical School Boston, 165 Cambridge Street, Suite 400, Boston, 02114-2750, MA
来源：
Current Cardiovascular Risk Reports | 2015年 / 9卷 / 6期
关键词：
Atherosclerosis; FDG-PET; Inflammation;
D O I：
10.1007/s12170-015-0459-0
中图分类号：
学科分类号：
摘要：
Atherosclerosis is a chronic inflammatory condition complicating cholesterol accumulation within the artery wall. Inflammation is believed to play an important role in the formation, progression, and ultimately the rupture of atherosclerotic plaques (the principle event leading to most myocardial infarctions and strokes). An enhanced understanding of the inflammatory process within the atheroma may therefore facilitate risk stratification and treatment strategies. Molecular imaging techniques such as PET/CT have the ability to quantify arterial inflammation and assess the high-risk features of atheromas thus may be useful for identifying patients who are at higher risk for an atherothrombotic event. In this review, we focus on the potential of FDG-PET/CT as a tool to measure arterial inflammation, enhance risk stratification, and to evaluate novel therapies directed against atherosclerotic disease. Additionally, this review will provide a discussion on current challenges as well as future directions. © 2015, Springer Science+Business Media New York.
引用
收藏
页码：1 / 8
页数：7
相关论文
共 65 条
  • [11] Butcher M.J., Galkina E.V., Phenotypic and functional heterogeneity of macrophages and dendritic cell subsets in the healthy and atherosclerosis-prone aorta, Front Physiol, 3, (2012)
  • [12] Wilcox J.N., Smith K.M., Schwartz S.M., Gordon D., Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque, Proc Natl Acad Sci U S A, 86, 8, pp. 2839-2843, (1989)
  • [13] Brown D.A., Breit S.N., Buring J., Fairlie W.D., Bauskin A.R., Liu T., Et al., Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case–control study, Lancet, 359, 9324, pp. 2159-2163, (2002)
  • [14] Ridker P.M., Buring J.E., Rifai N., Soluble P-selectin and the risk of future cardiovascular events, Circulation, 103, 4, pp. 491-495, (2001)
  • [15] Schonbek U., Varo N., Libby P., Buring J., Ridker P.M., Soluble CD 40 and cardiovascular risk in women, Circulation, 104, pp. 2266-2268, (2001)
  • [16] Ridker P.M., Hennekens C.H., Buring J.E., Rifai N., C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women, N Engl J Med, 342, 12, pp. 836-843, (2000)
  • [17] Ridker P.M., Rifai N., Rose L., Buring J.E., Cook N.R., Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events, N Engl J Med, 347, 20, pp. 1557-1565, (2002)
  • [18] Antoch G., Vogt F.M., Freudenberg L.S., Nazaradeh F., Goehde S.C., Barkhausen J., Et al., Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology, Jama, 290, 24, pp. 3199-3206, (2003)
  • [19] Lardinois D., Weder W., Hany T.F., Kamel E.M., Korom S., Seifert B., Et al., Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography, N Engl J Med, 348, 25, pp. 2500-2507, (2003)
  • [20] Graziosi M., Nanni C., Lorenzini M., Diemberger I., Bonfiglioli R., Pasquale F., Et al., Role of (1)(8)F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: a prospective study, Eur J Nucl Med Mol Imaging, 41, 8, pp. 1617-1623, (2014)
1234567